Los puntos clave no están disponibles para este artículo en este momento.
The burden and outcomes of inflammation in patients with atherosclerotic cardiovascular disease (ASCVD) are not well defined beyond the controlled settings of trials and research cohorts.
Mazhar et al. (Fri,) studied this question.